These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16286062)

  • 1. Life-threatening, preventable hyperkalemia in a nursing home resident: case report and literature review.
    Dharmarajan TS; Nguyen T; Russell RO
    J Am Med Dir Assoc; 2005; 6(6):400-5. PubMed ID: 16286062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life-threatening hyperkalemia: a potentially lethal drug combination.
    Juvet T; Gourineni VC; Ravi S; Zarich SW
    Conn Med; 2013 Sep; 77(8):491-3. PubMed ID: 24156179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
    Erden I; Yalcin S; Ozhan H
    Kardiol Pol; 2010 Sep; 68(9):1043-5; discussion 1046. PubMed ID: 20859899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP; Aaronson KD; Koelling TM
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy.
    Muzzarelli S; Maeder MT; Toggweiler S; Rickli H; Nietlispach F; Julius B; Burkard T; Pfisterer ME; Brunner-La Rocca HP;
    Am J Cardiol; 2012 Mar; 109(5):693-8. PubMed ID: 22152974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperkalemia and cardiac arrest associated with glucose replacement in a patient on spironolactone.
    Offman R; Paden A; Gwizdala A; Reeves JF
    Am J Emerg Med; 2017 Aug; 35(8):1214.e1-1214.e3. PubMed ID: 28549580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
    Fuster D; Frey FJ; Ferrari P
    Praxis (Bern 1994); 2000 Dec; 89(49):2073-6. PubMed ID: 11190849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia?
    Raebel MA; McClure DL; Chan KA; Simon SR; Feldstein AC; Lafata JE; Andrade SE; Gunter MJ; Nelson WW; Roblin D; Platt R
    Ann Pharmacother; 2007 Feb; 41(2):193-200. PubMed ID: 17284506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threatening hyperkalemia during a combined therapy with the angiotensin receptor blocker candesartan and spironolactone.
    Fujii H; Nakahama H; Yoshihara F; Nakamura S; Inenaga T; Kawano Y
    Kobe J Med Sci; 2005; 51(1-2):1-6. PubMed ID: 16199929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB; Rao K; Sawyer R; Gottlieb SS
    J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.
    Khosla N; Kalaitzidis R; Bakris GL
    Am J Nephrol; 2009; 30(5):418-24. PubMed ID: 19738369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in diagnosis and management of hypokalemic and hyperkalemic emergencies.
    Pepin J; Shields C
    Emerg Med Pract; 2012 Feb; 14(2):1-17; quiz 17-8. PubMed ID: 22413702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening hyperkalemia from nutritional supplements: uncommon or undiagnosed?
    John SK; Rangan Y; Block CA; Koff MD
    Am J Emerg Med; 2011 Nov; 29(9):1237.e1-2. PubMed ID: 21075579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automatic detection of spironolactone - related adverse drug events.
    Huang C; Noirot LA; Reichley RM; Bouselli DA; Dunagan WC; Bailey TC
    AMIA Annu Symp Proc; 2005; 2005():989. PubMed ID: 16779276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperkalemia. Main symptoms: muscle weakness, cardiac arrhythmias].
    Kolyvanos Naumann U; Käser L; Vetter W
    Praxis (Bern 1994); 2004 Jul; 93(29-30):1177-82, 1216. PubMed ID: 15359947
    [No Abstract]   [Full Text] [Related]  

  • 18. Appropriateness and complications of the use of spironolactone in patients treated in a heart failure clinic.
    Goland S; Naugolny V; Korbut Z; Rozen I; Caspi A; Malnick S
    Eur J Intern Med; 2011 Aug; 22(4):424-7. PubMed ID: 21767763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriateness of spironolactone prescribing in heart failure patients: a population-based study.
    Ko DT; Juurlink DN; Mamdani MM; You JJ; Wang JT; Donovan LR; Tu JV
    J Card Fail; 2006 Apr; 12(3):205-10. PubMed ID: 16624686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmias and ECG changes in life threatening hyperkalemia in older patients treated by potassium sparing drugs.
    Berkova M; Berka Z; Topinkova E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):84-91. PubMed ID: 23128820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.